Hormones, Pregnancy, and Contraception

For people who can become pregnant and have Protein S deficiency, hormones and pregnancy are important topics. Because Protein S acts as the “brakes” for your blood’s clotting system, and hormones like estrogen act as an “accelerator,” the combination can significantly shift your baseline risk ^[1][2]. Understanding these interactions allows you to make informed choices about birth control and pregnancy planning.

The Challenge of Estrogen

Estrogen-containing medications, such as combined oral contraceptives (the “pill”), patches, and vaginal rings, naturally lower the amount of Free Protein S in the blood ^[2][3]. For most people, this drop is manageable. However, if you already have a genetic deficiency, adding estrogen can increase your risk of a blood clot to roughly 4.3 to 4.6 per 100 “pill-years” in high-risk families ^[2].

Because of this, doctors strongly advise avoiding the use of combined estrogen-progestin products. You should unambiguously avoid estrogen-containing contraceptives and systemic estrogen hormone replacement therapy (HRT) if you have a confirmed Protein S deficiency ^[1][2]. Progestin-only options—such as the “mini-pill,” hormonal IUDs, or implants—are typically considered safer alternatives because they do not have the same dramatic impact on your clotting proteins. (Note: depot medroxyprogesterone injections may warrant more caution in people with thrombophilia or prior VTE. A nonhormonal copper IUD is also an option.) ^[4]

Pregnancy: The Natural Shift

During a healthy pregnancy, every woman’s body naturally lowers its Protein S levels and increases its clotting factors. This is an evolutionary “safety feature” designed to prevent excessive bleeding during childbirth ^[5][3].

If you already have a deficiency, this “natural shift” means your risk of a blood clot is highest during pregnancy and the weeks immediately following birth.

• Antepartum (During Pregnancy): The risk of a first blood clot is estimated in some observational family studies at roughly 0.9% for women with Protein S deficiency who are not on blood thinners ^[6].
• Postpartum (After Birth): This is the highest-risk window. The risk of a clot in the first 6 weeks after delivery is estimated in these same studies at 4.2% ^[6]. Because of this, depending on your prior VTE history and family history, you may be advised to use preventative blood thinners for at least 6 weeks after giving birth ^[6][5]. People with a prior VTE often need therapeutic treatment, while those without a prior VTE do not automatically receive the same antepartum or postpartum regimen.

Managing Your Pregnancy Journey

If you are pregnant or planning to be, your care will likely involve a multidisciplinary team including a hematologist and a Maternal-Fetal Medicine (high-risk OB/GYN) specialist. Never start or stop a blood thinner without a coordinated hematology and obstetric plan.

1. Medication: The standard of care is Low-Molecular-Weight Heparin (LMWH), such as enoxaparin. LMWH is preferred because it does not cross the placenta and is safe for the baby ^[7][5].
2. The Delivery Plan: To ensure you can safely receive neuraxial anesthesia (an epidural or spinal block), you must coordinate the timing of your last LMWH dose.
   • If you are on a low “prophylactic” dose, you typically need to wait at least 12 hours after your last shot before an epidural can be placed ^[8][9].
   • If you are on a higher “therapeutic” dose, the wait time is usually 24 hours ^[10][8].
3. Postpartum Recovery: You will likely restart your LMWH injections 6 to 24 hours after delivery, depending on the type of birth and any bleeding concerns ^[10]. This protection is vital because the risk of a pulmonary embolism is at its peak during these first few weeks ^[5].

Menopause and Beyond

As you transition into menopause, the same “estrogen rules” apply. Systemic Hormone Replacement Therapy (HRT) containing estrogen can increase the risk of blood clots ^[11]. If you require treatment for menopause symptoms, your doctor may suggest non-hormonal options. While transdermal (patch) estrogen is absorbed through the skin, it is not a universally safe workaround and still requires careful assessment of your thrombophilia history ^[11].

By working closely with your team, you can navigate these hormonal milestones safely, ensuring your “braking system” is supported when it needs it most.